Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana M Gonzalez-Angulo

Showing results (41-50 of 144) with videos related to

Pageof 15
Sort By:
Breast Cancer Research and Treatment|August 15, 2015
Recurrence and survival among breast cancer patients achieving a pathological complete response to neoadjuvant chemotherapyMisbat Chaudry, Xiudong Lei, Ana M Gonzalez-Angulo, et al.
Annals of Surgical Oncology|November 29, 2007
Development of new cancers in patients with DCIS: the M.D. Anderson experienceShaheenah Dawood, Kristine Broglio, Ana M Gonzalez-Angulo, et al.
Journal of Cancer|November 5, 2014
cMET Activation and EGFR-Directed Therapy Resistance in Triple-Negative Breast CancerJoohyuk Sohn, Shuying Liu, Napa Parinyanitikul, et al.
Cancer|July 9, 2004
Lack of association between amplification of her-2 and response to preoperative taxanes in patients with breast carcinomaAna M Gonzalez-Angulo, Savitri Krishnamurthy, Yuko Yamamura, et al.
Oncotarget|May 15, 2015
Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype?Fanny Le Du, Bedrich L Eckhardt, Bora Lim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
p53 expression as a prognostic marker in inflammatory breast cancerAna M Gonzalez-Angulo, Nour Sneige, Aman U Buzdar, et al.
Contemporary Clinical Trials|September 25, 2012
Integrating comparative effectiveness design elements and endpoints into a phase III, randomized clinical trial (SWOG S1007) evaluating oncotypeDX-guided management for women with breast cancer involving lymph nodesScott D Ramsey, William E Barlow, Ana M Gonzalez-Angulo, et al.
Cancer|July 30, 2011
Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancerSoley Bayraktar, Leonel F Hernadez-Aya, Xiudong Lei, et al.
The Breast Journal|July 15, 2010
Trastuzumab in Primary Inflammatory Breast Cancer (IBC): High Pathological Response Rates and Improved OutcomeShaheenah Dawood, Yun Gong, Kristine Broglio, et al.
Annals of Surgical Oncology|November 10, 2010
Impact of progression during neoadjuvant chemotherapy on surgical management of breast cancerAbigail S Caudle, Ana M Gonzalez-Angulo, Kelly K Hunt, et al.
Pageof 15

Showing results (41-50 of 144) with videos related to

Sort By:
Pageof 15
Breast Cancer Research and Treatment|August 15, 2015
Recurrence and survival among breast cancer patients achieving a pathological complete response to neoadjuvant chemotherapyMisbat Chaudry, Xiudong Lei, Ana M Gonzalez-Angulo, et al.
Annals of Surgical Oncology|November 29, 2007
Development of new cancers in patients with DCIS: the M.D. Anderson experienceShaheenah Dawood, Kristine Broglio, Ana M Gonzalez-Angulo, et al.
Journal of Cancer|November 5, 2014
cMET Activation and EGFR-Directed Therapy Resistance in Triple-Negative Breast CancerJoohyuk Sohn, Shuying Liu, Napa Parinyanitikul, et al.
Cancer|July 9, 2004
Lack of association between amplification of her-2 and response to preoperative taxanes in patients with breast carcinomaAna M Gonzalez-Angulo, Savitri Krishnamurthy, Yuko Yamamura, et al.
Oncotarget|May 15, 2015
Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype?Fanny Le Du, Bedrich L Eckhardt, Bora Lim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
p53 expression as a prognostic marker in inflammatory breast cancerAna M Gonzalez-Angulo, Nour Sneige, Aman U Buzdar, et al.
Contemporary Clinical Trials|September 25, 2012
Integrating comparative effectiveness design elements and endpoints into a phase III, randomized clinical trial (SWOG S1007) evaluating oncotypeDX-guided management for women with breast cancer involving lymph nodesScott D Ramsey, William E Barlow, Ana M Gonzalez-Angulo, et al.
Cancer|July 30, 2011
Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancerSoley Bayraktar, Leonel F Hernadez-Aya, Xiudong Lei, et al.
The Breast Journal|July 15, 2010
Trastuzumab in Primary Inflammatory Breast Cancer (IBC): High Pathological Response Rates and Improved OutcomeShaheenah Dawood, Yun Gong, Kristine Broglio, et al.
Annals of Surgical Oncology|November 10, 2010
Impact of progression during neoadjuvant chemotherapy on surgical management of breast cancerAbigail S Caudle, Ana M Gonzalez-Angulo, Kelly K Hunt, et al.
Pageof 15